Absci’s Integrated Drug Creation™ platform begins with the Data to Train. Absci is a biotechnology company focused on revolutionizing drug discovery through the innovative use of generative artificial intelligence (AI).…
Omisirge is the world’s 1st U.S. FDA approved product that is a expanded umbilical cord blood cell therapy. It is also the only allogeneic stem cell therapy approved by the…
Tradename: VARIVAX Proper Name: Varicella Virus Vaccine Live Indication: To include safety and immunogenicity data that supports the intramuscular route as an additional route of administration for VARIVAX, and associated…
Drug Name: Aphexda Active Ingredient: motixafortide Indications: To use with filgrastim (G-CSF) to mobilize hematopoietic stem cells to the peripheral blood for collection and subsequent autologous transplantation in patients with…
Tradename: ABRYSVO Proper Name: Respiratory Syncytial Virus Vaccine Indication: Indicated for active immunization of pregnant individuals at 32 through 36 weeks gestational age for the prevention of lower respiratory…
Tradename: ERVEBO Proper Name: Ebola Zaire Vaccine, Live Indication: To extend the indication for use to include individuals 12 months of age and older. ERVEBO is a vaccine indicated for…
Tradename: BALFAXAR Proper Name: prothrombin complex concentrate, human-lans Indication: Indicated for the urgent reversal of acquired coagulation factor deficiency induced by Vitamin K antagonist (VKA, e.g., warfarin) therapy in adult…
Tradename: CYFENDUS Proper Name: Anthrax Vaccine Adsorbed, Adjuvanted Indication: Indicated for post-exposure prophylaxis of disease following suspected or confirmed exposure to Bacillus anthracis in persons 18 through 65 years of…
Tradename: DENGVAXIA Proper Name: Dengue Tetravalent Vaccine, Live Indication: To include safety and efficacy data that support the use of DENGVAXIA in individuals 6 through 16 years of age with…
Tradename: ROCTAVIAN Proper Name: valoctocogene roxaparvovec-rvox Indication: Valoctocogene roxaparvovec-rvox is an adeno-associated virus vector-based gene therapy indicated for the treatment of adults with severe hemophilia A (congenital factor VIII deficiency…